-
Rewriting the rulebook on schizophrenia meds: Why it's time to rethink clozapine protocols
The most effective antipsychotic drug for people with treatment-resistant schizophrenia is clozapine. Yet, across the world, it remains underused—largely due... Read more -
FDA to revise labeling of ADHD medication to indicate weight loss risk
The U.S. Food and Drug Administration is revising the labeling of all extended-release attention-deficit/hyperactivity disorder (ADHD) medications, including certain formulations... Read more -
Too many medicines, too many hospital visits: Study highlights hidden risk for older adults
Inappropriate polypharmacy—the excessive or unnecessary use of multiple medications—is a major driver of emergency hospital admissions among adults aged 65... Read more -
Antibody-cancer drug combo shows promise against aggressive lymphoma
Cancer-hunting antibodies coupled with a natural compound found in soil microbes proved a powerful combination against an aggressive type of... Read more -
Royalty-based investment model could bridge 'valley of death' between drug discovery and delivery
A team of researchers from the MIT Sloan School of Management, the Sean M. Healey & AMG Center for ALS... Read more -
Motion sickness drug linked to cases of robbery and assault. Here's what you need to know about 'devil's breath'
Scopolamine, more chillingly known as "devil's breath," is a drug with a dual identity. In medicine, it's used to prevent... Read more -
Nearly 1 in 6 older adults take aspirin despite no history of heart disease
Around 1 in 6 older adults take aspirin as their primary method of preventing cardiovascular disease—despite stricter guidelines that no... Read more -
Tens of thousands of heart attacks, strokes could be prevented with this prescription, study suggests
Tens of thousands of people suffer needless heart attacks and strokes every year because they aren't taking cholesterol-lowering drugs, a... Read more -
Black emergency department patients less likely to be treated with opioids, more likely to misuse them later
A new study examining racial disparities in unmet pain treatment finds that patients suffering from acute pain whose opioid treatment... Read more -
Degree of weight loss affects tirzepatide-linked cardiometabolic risk improvement: Study
For adults with obesity or overweight, tirzepatide-linked improvements in cardiometabolic risk factors are associated with the degree of weight reduction,... Read more -
Ozempic-like drug significantly reduces frequency of chronic migraines in pilot study
Migraines are a common ailment worldwide, affecting nearly 15% of the global population. At times, they can be debilitating enough... Read more -
First oral drug shows promise for Barth syndrome heart and muscle symptoms
Researchers at Tohoku University have discovered that an oral drug called MA-5 can improve both heart and muscle problems in... Read more -
Experimental medication wipes out aggressive brain cancer tumors by targeting cellular 'motors'
A potential treatment for glioblastoma crafted by scientists at The Wertheim UF Scripps Institute renders the deadly brain cancer newly... Read more -
Novel drug tackles uncontrolled hypertension caused by aldosterone dysregulation
Hypertension affects 1 in 3 adults globally and is the leading modifiable risk factor for cardiovascular disease. Aldosterone dysregulation, often... Read more -
The most effective diabetes drugs don't reach enough patients yet, analysis finds
A UCSF analysis has found that the newer generation of much more effective diabetes medications are reaching only a fraction... Read more
